Sign in
4

Changes in Ownership

ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001053369-17-000006

Director acquired 68,518 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Caskey Davis S Director 2017-02-23 Grant or award +68,518 $0.20 $13,443 68,518 D: show line 1 in the form
Loading xslF345X03/primary_doc.xml…